The Global C-Reactive Protein Testing Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there is inflammation in the body.
Scope of the Report:
C-reactive tests identify and keep track of infections and diseases that cause inflammation such as certain types of cancers, cardiovascular diseases, arthritis, etc. C-reactive protein tests estimate the risks of a person suffering from heart attacks or strokes.
The global C-Reactive Protein Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of C-Reactive Protein Testing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the C-Reactive Protein Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the C-Reactive Protein Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Roche
- EMD Millipore
- Life technologies
- Randox
- Quest Diagnostics
- Abaxis
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- ELISA
- Immunoturbidimetric
- Chemiluminesence immunoassay(CLIA)
- High-sensitivity C-reactive protein (hsCRP) assay
Market Segment by Applications, can be divided into
- Cardiovascular diseases
- Infections
- Diseases of immune system
- Rhematoid arthritis
- Cancers
- Inflammatory bowel disease
- Osteomyelitis